e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Issues in the management of COPD in the community
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Respiratory symptoms as predictor of impairment in COPD: the Guangzhou Biobank cohort study
K. H. Lam, R. E. Jordan, M. R. Miller, C. Q. Jiang, T. H. Lam, K. K. Cheng, P. Adab (Birmingham, United Kingdom; Guangzhou, Hong Kong, China)
Source:
Annual Congress 2008 - Issues in the management of COPD in the community
Session:
Issues in the management of COPD in the community
Session type:
Thematic Poster Session
Number:
3516
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. H. Lam, R. E. Jordan, M. R. Miller, C. Q. Jiang, T. H. Lam, K. K. Cheng, P. Adab (Birmingham, United Kingdom; Guangzhou, Hong Kong, China). Respiratory symptoms as predictor of impairment in COPD: the Guangzhou Biobank cohort study. Eur Respir J 2008; 32: Suppl. 52, 3516
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Risk of cardiovascular events following COPD hospitalisation: Findings from the China Kadoorie Biobank cohort study
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
Work-related COPD risk in the population-based UK Biobank cohort study
Source: International Congress 2015 – Occupational factors in COPD and bronchitis
Year: 2015
Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Respiratory symptoms in COPD: a comparison between the UK and China
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008
Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Introducing the UK Biobank cohort study – what‘s in it for respiratory disease?
Source: Eur Respir J 2005; 26: Suppl. 49, 597s
Year: 2005
Lung function and respiratory symptoms as predictors of mortality: The HUNT study
Source: Annual Congress 2012 - Methodology in epidemiologic research
Year: 2012
Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study
Source: Eur Respir J 2014; 43: 1289-1297
Year: 2014
Undiagnosed COPD: who is at risk, and does it matter? The Guangzhou biobank cohort study (GBCS)
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009
Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Long-term survivalaccording to Czech clinical phenotypes of COPD- Czech multicentre research database of severe COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Childhood wheeze – A risk factor for COPD? A 50-year cohort study
Source: International Congress 2015 – Respiratory health across the life course
Year: 2015
Air pollution, lung function and COPD: results from the population-based UK Biobank study
Source: Eur Respir J, 54 (1) 1802140; 10.1183/13993003.02140-2018
Year: 2019
CPOD and lung function parameters as predictors of mortality: Results from the Latin American PLATINO cohort study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Lung function (LF) decline and hospitalization in subjects with the asthma-COPD overlap syndrome
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Respiratory parameters predict mortality in COPD patients - data from the Czech multicentre research database of severe COPD.
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Association between functionality and respiratory impairment after hospitalization for COVID-19: a cohort study
Source: Virtual Congress 2021 – COVID-19: insights from respiratory physiotherapists
Year: 2021
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Prevalence of co-morbidities in a Hellenic COPD population (COMPACT study)
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept